UFlex net debt rises to Rs 9,039 crore, leverage falls
Key highlights
- UFlex reported net debt of Rs 9,039 crore at September 2026, up from Rs 8,621.8 crore at March 2026.
- UFlex's net debt-to-annualised normalized EBITDA ratio fell to 3.42 times from 4.51 times at March 2026.
- UFlex's H1 FY27 normalized EBITDA rose 85.7% year on year to Rs 1,596.1 crore.
- UFlex's term loans accounted for Rs 8,162.6 crore, or 76%, of September 2026 gross debt.
powered by IRIS

UFlex reported net debt of Rs 9,039 crore at September 30, 2026, up from Rs 8,621.8 crore at March 2026, but net debt to annualised normalized earnings before interest, tax, depreciation and amortisation (EBITDA) declined to 3.42 times from 4.51 times as H1 FY27 normalized EBITDA rose 85.7% year on year.
Know Uflex inside out
Results, valuation, peers and who's buying, in one view.
How much did UFlex debt change by September 2026?
UFlex's gross debt rose to Rs 10,722.1 crore at September 2026 from Rs 9,852.6 crore at March 2026, while net debt increased by Rs 417.2 crore to Rs 9,039 crore. Gross debt was also Rs 1,632.5 crore higher than the Rs 9,089.6 crore reported at September 2025.
The gap between gross debt and net debt widened to Rs 1,683.1 crore at September 2026 from Rs 1,230.8 crore at March 2026. UFlex states that its cash and cash-equivalent calculation includes cash, bank balances, other non-current financial assets such as fixed deposits and margin-money deposits exceeding 12 months, and debt-service coverage account balances held with lender banks.
The longer trend shows that debt had been increasing before FY27. UFlex's gross debt rose from Rs 2,140 crore in FY16 to Rs 9,852.6 crore in FY26, while net debt increased from Rs 1,680 crore to Rs 8,621.8 crore over the same period.
Why did UFlex leverage fall despite higher net debt?
UFlex's leverage ratio fell because the annualised normalized EBITDA used in the calculation increased while net debt rose. Net debt to normalized EBITDA declined by 1.09 times from 4.51 times at March 2026 to 3.42 times at September 2026, and was lower than 3.77 times at June 2026.
Normalized EBITDA reached Rs 1,596.1 crore in H1 FY27, up 85.7% from Rs 859.3 crore in H1 FY26. Revenue increased 31.9% year on year to Rs 10,266.6 crore, while normalized EBITDA margin expanded to 15.5% from 11.0%, a gain of 450 basis points. One basis point equals one-hundredth of a percentage point.
UFlex separately reported net debt to reported EBITDA of 3.33 times at September 2026, compared with 4.35 times at March 2026. Reported EBITDA was Rs 1,632.4 crore in H1 FY27, up 81.9% from Rs 897.5 crore in H1 FY26.
Quarterly normalized EBITDA fell sequentially but remained above the prior-year level. Q2 FY27 normalized EBITDA was Rs 758.8 crore, down 9.4% from Rs 837.3 crore in Q1 FY27, but up 94.8% from Rs 389.5 crore in Q2 FY26; its margin was 15.6%, versus 15.5% and 10.1%, respectively.
Got a follow-up? Ask IRIS
What is UFlex's debt mix by type and geography?
UFlex's September 2026 gross debt comprised Rs 8,162.6 crore of term loans, representing 76%, and Rs 2,559.5 crore of working-capital and short-term debt, representing 24%. Term loans were Rs 7,355.6 crore at March 2026, compared with Rs 8,162.6 crore at September 2026.
Overseas debt accounted for Rs 5,660 crore, or 53% of gross debt, while Indian debt accounted for Rs 5,062 crore, or 47%. Overseas term loans were Rs 4,246 crore and overseas working-capital and short-term facilities were Rs 1,414 crore; the corresponding Indian balances were Rs 3,916 crore and Rs 1,146 crore.
UFlex disclosed CRISIL AA-/Stable for long-term borrowings and CRISIL A1+ for short-term borrowings as of May 2025. It also disclosed India Ratings' Ind AA-/Stable and IND A1+ ratings as of September 2025, while providing no repayment schedule, interest-rate detail or debt-reduction target for the September 2026 balance.
Finance costs were Rs 448.9 crore in H1 FY27, up 16.0% from Rs 386.9 crore in H1 FY26. Q2 FY27 finance costs were Rs 232.7 crore, 7.6% above Rs 216.3 crore in Q1 FY27, and these costs are reported separately from normalized EBITDA.
What balance-sheet changes accompanied UFlex's debt increase?
UFlex's total assets increased to Rs 24,750.1 crore at September 30, 2026 from Rs 22,171.4 crore at March 31, 2026. Property, plant and equipment rose by Rs 582.1 crore to Rs 9,520 crore, while capital work-in-progress declined by Rs 133 crore to Rs 2,036.2 crore.
Current assets rose to Rs 10,908.4 crore from Rs 8,988.2 crore over the same six months. Inventories increased by Rs 756.4 crore to Rs 3,164.7 crore, trade receivables rose by Rs 537.1 crore to Rs 4,397.9 crore, and cash and cash equivalents increased to Rs 1,365.4 crore from Rs 984.4 crore.
UFlex reported capital expenditure of Rs 1,047.1 crore in H1 FY27, following Rs 2,042.6 crore in FY26 and Rs 1,725.8 crore in FY25. The presentation does not allocate H1 FY27 capital expenditure by project, geography or financing source.
Packaging-film sales volume was 265,211 metric tonnes in H1 FY27, up 4.0% from 255,032 metric tonnes in H1 FY26. Middle East and Africa volume rose 11.6% to 75,630 metric tonnes and Americas volume increased 12.0% to 59,267 metric tonnes, while India volume declined 5.2% to 62,180 metric tonnes.
Conclusion
UFlex's September 2026 debt data show higher absolute borrowing alongside a lower earnings-based leverage measure. Net debt increased to Rs 9,039 crore and gross debt reached Rs 10,722.1 crore, but the net debt-to-annualised normalized EBITDA ratio declined to 3.42 times as H1 FY27 normalized EBITDA increased 85.7% and its margin rose to 15.5%.
The unresolved issue is whether debt growth, which lifted gross debt by Rs 869.5 crore from March to September 2026, continues alongside capital expenditure of Rs 1,047.1 crore in H1 FY27. UFlex has not disclosed a deleveraging target, repayment timetable or project-level allocation of that half-year capital expenditure.


